Cargando…
Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
Background: Alpha-1 antitrypsin deficiency (A1ATD) is a progressive lung disease caused by inherited pathogenic variants in the SERPINA1 gene. However, their actual role in maintenance of structural and functional characteristics of the corresponding α-1 anti-trypsin (A1AT) protein is not well chara...
Autores principales: | Shaik, Noor Ahmad, Saud Al-Saud, Najla Bint, Abdulhamid Aljuhani, Thamer, Jamil, Kaiser, Alnuman, Huda, Aljeaid, Deema, Sultana, Nasreen, El-Harouni, Ashraf AbdulRahman, Awan, Zuhier Ahmed, Elango, Ramu, Banaganapalli, Babajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730039/ https://www.ncbi.nlm.nih.gov/pubmed/36504721 http://dx.doi.org/10.3389/fmolb.2022.1051511 |
Ejemplares similares
-
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018) -
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020) -
Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015) -
Paget’s disease: a review of the epidemiology, etiology, genetics, and treatment
por: Banaganapalli, Babajan, et al.
Publicado: (2023) -
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)